Zydus Cadila

Photo: The News Minute

COVID Drug 'Virafin' By Zydus To Cost Rs 11,995 Per Dose

Pharmaceutical giant Zydus Cadila has announced that a dose of its COVID-19 drug 'Virafin' will cost Rs 11,995. The company has claimed that Virafin will lessen the need for oxygen in COVID-19 patients. The drug was earlier approved by the Drug Controller General of India on April 23 for treatment of mild COVID-19 cases.  Meanwhile, Zydus is also in the process to launch its three-dose COVID-19 vaccine Zy-CoV-D.

Wed, 12 May 2021 - 12:39 PM / by Nikita Thakur

Tags: Zydus Cadila, Virafin, Covid-19, Covid Vaccine

Courtesy: India Today

Zydus Cadila

Photo: The News Minute

DCGI Nods Emergency Use Of Zydus Cadila's 'Virafin' For Moderate COVID-19

The Drugs Controller General of India on April 23 approved the emergency use of Zydus Cadila's Pegylated Interferon alpha-2b (PegIFN), ‘Virafin' to treat moderately infected COVID patients. Reportedly, Zydus claims that 91.5% of patients administered with this drug have shown fast recovery while requiring less oxygen for treatment. Interestingly, they also tested negative on RT-PCR test by day 7. India recorded 3.32 lakh fresh COVID-19 cases… read-more

Fri, 23 Apr 2021 - 07:28 PM / by Neha Sanjeev

Tags: Virafin, DCGI, Covid-19, drug, Indian Pharma

Courtesy: Times Now news